Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

Brian Druker steps down as CEO of OHSU Knight Cancer Center

On Dec. 3, the faculty and staff members at the OHSU Knight Cancer Institute received an email from Brian J. Druker, the institution’s star scientist, former director, and current CEO, informing them that he would be stepping down from his executive role.

Michael Wong joins Roswell Park as physician-in-chief

Michael Wong joined Roswell Park Comprehensive Cancer Center as the center’s first physician-in-chief.

December 06, 2024

Vol.50 No.45

Drugs & Targets

ConcertAI and NeoGenomics announce AI software-as-a-service solution for hematology clinical research

ConcertAI announced a joint software-as-a-service solution in hematological malignancies for research analytics, clinical trial design, and clinical trial operational optimization.

December 06, 2024

Vol.50 No.45

Conversation with The Cancer Letter

Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinics
The state has the second highest (and rising) cancer rates in the U.S.

A curious piece of paper hangs in a frame outside the director’s office at University of Iowa Holden Comprehensive Cancer Center on the second floor of the General Hospital.

Thomas Bradley named director of hematology and oncology at Northwell’s Florina Cancer Center

Thomas Bradley has been appointed director of hematology and oncology at Staten Island University Hospital’s Florina Cancer Center to spearhead the division’s clinical, educational, and research initiatives.

October 25, 2024

Vol.50 No.40

ACS board member Wayne Frederick steps in as interim CEO, replacing Karen Knudsen
National search will be conducted

Wayne A. I. Frederick, a surgical oncologist and former president of Howard University, will step in as interim chief executive officer of the American Cancer Society, effective Nov. 2.

October 18, 2024

Vol.50 No.39

By Paul Goldberg

Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

YOU MAY BE INTERESTED IN

Brian Druker steps down as CEO of OHSU Knight Cancer Center

Michael Wong joins Roswell Park as physician-in-chief

ConcertAI and NeoGenomics announce AI software-as-a-service solution for hematology clinical research

Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinics
The state has the second highest (and rising) cancer rates in the U.S.

Thomas Bradley named director of hematology and oncology at Northwell’s Florina Cancer Center

ACS board member Wayne Frederick steps in as interim CEO, replacing Karen Knudsen
National search will be conducted

Renew today!

Subscriber content

Never miss an issue!

Login

Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

YOU MAY BE INTERESTED IN

Brian Druker steps down as CEO of OHSU Knight Cancer Center

Michael Wong joins Roswell Park as physician-in-chief

ConcertAI and NeoGenomics announce AI software-as-a-service solution for hematology clinical research

Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinicsThe state has the second highest (and rising) cancer rates in the U.S.

Thomas Bradley named director of hematology and oncology at Northwell’s Florina Cancer Center

ACS board member Wayne Frederick steps in as interim CEO, replacing Karen KnudsenNational search will be conducted

Never miss an issue!

Login

Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinics
The state has the second highest (and rising) cancer rates in the U.S.

ACS board member Wayne Frederick steps in as interim CEO, replacing Karen Knudsen
National search will be conducted